Q4 2024 Management View CEO Linden Evans highlighted the company’s strong performance in 2024, achieving a 4.3% EPS growth and meeting earnings guidance despite challenges such as mild weather and ...
Strategic planning is not a one-time activity but an ongoing commitment to methodically aligning an RIA’s goals with its core values and purpose. Creating a single-page snapshot of five-year, one-year ...
With the strategic restructuring, X4 aims to improve operational and capital efficiency, focus on the ongoing Phase 3 clinical trial of mavorixafor in chronic neutropenia, and optimize U.S. promotion ...